Blau Farmaceutica SA
BOVESPA:BLAU3

Watchlist Manager
Blau Farmaceutica SA Logo
Blau Farmaceutica SA
BOVESPA:BLAU3
Watchlist
Price: 13.01 BRL -0.08% Market Closed
Market Cap: 2.3B BRL

Intrinsic Value

The intrinsic value of one BLAU3 stock under the Base Case scenario is hidden BRL. Compared to the current market price of 13.01 BRL, Blau Farmaceutica SA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLAU3 Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Blau Farmaceutica SA

Intrinsic Value History
Dive into the past to invest in the future

BLAU3 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BLAU3 is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BLAU3?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BLAU3 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Blau Farmaceutica SA.

Explain Valuation
Compare BLAU3 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BLAU3?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Blau Farmaceutica SA

Current Assets 1.6B
Cash & Short-Term Investments 297.9m
Receivables 649.8m
Other Current Assets 678.2m
Non-Current Assets 1.8B
Long-Term Investments 265.2m
PP&E 932.3m
Intangibles 533.8m
Other Non-Current Assets 113.4m
Current Liabilities 513.4m
Accounts Payable 273m
Accrued Liabilities 73.1m
Other Current Liabilities 167.3m
Non-Current Liabilities 691.1m
Long-Term Debt 431m
Other Non-Current Liabilities 260.1m
Efficiency

Free Cash Flow Analysis
Blau Farmaceutica SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Blau Farmaceutica SA

Revenue
1.8B BRL
Cost of Revenue
-1.1B BRL
Gross Profit
706.1m BRL
Operating Expenses
-283.9m BRL
Operating Income
422.1m BRL
Other Expenses
-139.5m BRL
Net Income
282.7m BRL
Fundamental Scores

BLAU3 Profitability Score
Profitability Due Diligence

Blau Farmaceutica SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Operating Margin
Positive 3Y Average ROIC
Sustainable 3Y Average Operating Margin
Positive 3Y Average ROE
hidden
Profitability
Score

Blau Farmaceutica SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BLAU3 Solvency Score
Solvency Due Diligence

Blau Farmaceutica SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
hidden
Solvency
Score

Blau Farmaceutica SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLAU3 Price Targets Summary
Blau Farmaceutica SA

Wall Street analysts forecast BLAU3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLAU3 is 16.54 BRL with a low forecast of 14.95 BRL and a high forecast of 19.95 BRL.

Lowest
Price Target
14.95 BRL
15% Upside
Average
Price Target
16.54 BRL
27% Upside
Highest
Price Target
19.95 BRL
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BLAU3 is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BLAU3 stock?

The intrinsic value of one BLAU3 stock under the Base Case scenario is hidden BRL.

Is BLAU3 stock undervalued or overvalued?

Compared to the current market price of 13.01 BRL, Blau Farmaceutica SA is hidden .

Back to Top